EUVIMEDEUVIMED entdecken
Pragmatische StudieRandomisierte kontrollierte StudieOpen Access

A Randomized Trial of Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting

Shivan J Mehta, Sanjay Palat, Caitlin McDonald, Catherine Reitz, Evelyn Okorie, Keyirah Williams, Jinming Tao, Pamela A Shaw, Karen Glanz, David A Asch

Clinical Gastroenterology and Hepatology · 2024-10 · 22 (10) · 2117-2124.e2

DOI: 10.1016/j.cgh.2024.04.003 ↗

Kurz gefasst

Pragmatische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-10. Verfasst von Shivan J Mehta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Health Care Innovation, Unive…. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Mailed outreach for colorectal cancer (CRC) screening increases uptake but it is unclear how to offer the choice of testing. We evaluated if the active choice between colonoscopy and fecal immunochemical test (FIT), or FIT alone, increased response compared with colonoscopy alone. METHODS: This pragmatic, randomized, controlled trial at a community health center included patients between ages 50 and 74 who were not up to date with CRC screening. Patients were randomized 1:1:1 to the following: (1) colonoscopy only, (2) active choice of colonoscopy or FIT, or (3) FIT only. Patients received an outreach letter with instructions for testing (colonoscopy referral and/or an enclosed FIT kit), a reminder letter at 2 months, and another reminder at 3 to 5 months via text message or automated voice recording. The primary outcome was CRC screening completion within 6 months. RESULTS: Among 738 patients in the final analysis, the mean age was 58.7 years (SD, 6.2 y); 48.6% were insured by Medicaid and 24.3% were insured by Medicare; and 71.7% were White, 16.9% were Black, and 7.3% were Hispanic/Latino. At 6 months, 5.6% (95% CI, 2.8-8.5) completed screening in the colonoscopy-only arm, 12.8% (95% CI, 8.6-17.0) in the active-choice arm, and 11.3% (95% CI, 7.4-15.3) in the FIT-only arm. Compared with colonoscopy only, there was a significant increase in screening in active choice (absolute difference, 7.1%; 95% CI, 2.0-12.2; P = .006) and FIT only (absolute difference, 5.7%; 95% CI, 0.8-10.6; P = .02). CONCLUSIONS: Both choice of testing and FIT alone increased response and may align with patient preferences. TRIAL REGISTRATION: clinicaltrials.gov NCT04711473.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColonoscopyColorectal NeoplasmsEarly Detection of CancerAgedFemaleHumansMaleMiddle AgedOccult BloodPatient Acceptance of Health CarePostal Service

Stichwörter der Autor:innen

Behavioral EconomicsChoice ArchitectureColorectal Cancer ScreeningCommunity HealthOutreach

Autor:innen und Institutionen

  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Health Care Innovation, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address:…
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Health Care Innovation, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Ph…
  • Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health
  • National Comprehensive Cancer Network Foundation
  • National Comprehensive Cancer Network

Zitieren

APA

Mehta, S. J., Palat, S., McDonald, C., Reitz, C., Okorie, E., Williams, K., Tao, J., Shaw, P. A., Glanz, K., & Asch, D. A. (2024). A Randomized Trial of Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting. Clinical Gastroenterology and Hepatology, 22(10), 2117-2124.e2. https://doi.org/10.1016/j.cgh.2024.04.003

Vancouver

Mehta SJ, Palat S, McDonald C, Reitz C, Okorie E, Williams K, et al. A Randomized Trial of Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting. Clinical Gastroenterology and Hepatology. 2024;22(10):2117-2124.e2. doi:10.1016/j.cgh.2024.04.003

BibTeX
@article{Mehta2024,
  author = {Mehta, Shivan J and Palat, Sanjay and McDonald, Caitlin and Reitz, Catherine and Okorie, Evelyn and Williams, Keyirah and Tao, Jinming and Shaw, Pamela A and Glanz, Karen and Asch, David A},
  title = {A Randomized Trial of Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  volume = {22},
  number = {10},
  pages = {2117--2124.e2},
  doi = {10.1016/j.cgh.2024.04.003}
}
Kostenlos starten →